Ovarian cancer has historically been called a “ silent killer ,” because clinicians thought its symptoms were undetectable. Patients were often diagnosed so late that doctors thought nothing could be ...

Further assessment is needed to understand if these treatment recommendations were eventually adopted and if adoption leads to better outcomes,” researchers wrote.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

In a deal with prosecutors, Mark Albert Rettenmaier admitted to downloading more than 200 images on several electronic devices.

J. Scott Cordova, M.D., Ph.D., has joined the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller ...

Three of the leading chatbots can provide basic information about endometriosis, a painful gynecologic condition that affects ...

Uterine cancer (also known as endometrial cancer) is the fourth most common cancer women in the U.S. are diagnosed with. It ...

In a deal with prosecutors, Mark Albert Rettenmaier admitted to downloading more than 200 images on several electronic ...

SSM Health Medical Group is pleased to welcome Kennedy Barrett, APRN, an advanced practice registered nurse, to its ...

What Now' second annual summit, experts discussed social media, misinformaiton and influencers in health advocacy.

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

On-demand video webcast now available here FORT LAUDERDALE, FL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), ...